30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Studies demonstrated that N8 Medical's ceragenin-based CSA-90 compound promoted union of fractured bone while preventing infection in mouse models. The company will pursue broad clinical orthopaedic applications for the technology, including open fractures, spinal fusions, bone cement, etc. (N8 Medical, 3/4/15)